IN THE HOLISTIC DEVELOPMENT OF THE NEW 5.5 ML STAKED-NEEDLE GLASS PFS, SCHOTT PHARMA CONSIDERED ALL THESE FACTORS AND COLLABORATED WITH ITS PARTNERS TO IDENTIFY THE BEST SOLUTION. When developing a PFS, the needs of all stakeholders should be taken into account
The company notes that various circumstances may affect delivery timelines
Disclaimers & Attributions Brand References: Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S
Side effects and medical concerns Muscle Loss: A meaningful portion of the weight loss is coming from muscle mass, which can be harmful, especially for older adults or frail individuals
Arillotta D, Floresta G, Papanti Pelletier GD, Guirguis A, Corkery JM, Martinotti G, Schifano F